Do Big Money Love Charles River Laboratories International Inc (NYSE:CRL), Sentiment at 1.13

June 29, 2018 - By Kevin Carney

Charles River Laboratories International, Inc. (NYSE:CRL) Corporate Logo

Charles River Laboratories International Inc’s Sentiment

In 2018 Q1 Charles River Laboratories International Inc (NYSE:CRL) big money sentiment increased to 1.13, according to SEC filings. That’s up 0.05, from 2017Q4’s 1.08. 140 institutional investors increased or started new positions, while 124 sold and trimmed equity positions in Charles River Laboratories International Inc so the sentiment is better. Funds own 44.28 million shares, down from 44.57 million shares in 2017Q4. Funds holding Charles River Laboratories International Inc in top 10 changed to 1 from 2 for a decrease of 1. 31 Investors Sold All; 93 Reduced Holdings; 96 increased holdings while 44 institutional investors bought holdings.

Biggest Charles River Laboratories International Inc Shareholders

As of 2018 Q1 Channing Capital Management Llc has 2.62% invested in Charles River Laboratories International Inc. As of 2018 Q1, 613,141 shares of Charles River Laboratories International Inc are owned by Van Berkom & Associates Inc.. Copper Rock Capital Partners Llc reported 301,980 shares. Ariel Investments Llc revealed 1.36 million shares position in Charles River Laboratories International Inc. The Michigan-based fund Norris Perne & French Llp Mi looks positive on Charles River Laboratories International Inc, owning 99,543 shares.

Charles River Laboratories International, Inc., an early-stage contract research company, provides drug discovery and development services worldwide.The firm is valued at $5.40 billion. It operates through three divisions: Research Models and Services , Discovery and Safety Assessment (DSA), and Manufacturing Support (Manufacturing).42.52 is the P/E ratio. The RMS segment produces and sells research model strains primarily genetically and microbiologically defined purpose-bred rats and mice for use by researchers.

Ticker’s shares touched $112.69 during the last trading session after 1.32% change.Charles River Laboratories International, Inc. has volume of 53,270 shares. Since June 29, 2017 CRL has risen 12.87% and is uptrending. CRL outperformed by 0.30% the S&P500.

On August, 8 WallStreet awaited Charles River Laboratories International, Inc. (NYSE:CRL)’s earnings report, according to Faxor. Analysts predict $1.47 EPS. That’s $0.18 up or 13.95 % from 2017’s earnings of $1.29. CRL’s profit could hit $70.43M if the current EPS of $1.47 is accurate. 6.52 % EPS growth is what analysts predict. $1.38 EPS was revealed for previous quarter.

Bnp Paribas Arbitrage Sa holds 33,730 shs. Bbva Compass Commercial Bank accumulated 5,656 shs. Stone Ridge Asset Mgmt Limited Liability Com has invested 0.04% in Charles River Laboratories International, Inc. (NYSE:CRL). Manufacturers Life Insurance Co The owns 75,862 shs. California Public Employees Retirement Systems owns 0.01% invested in Charles River Laboratories International, Inc. (NYSE:CRL) for 97,831 shs. Channing Cap Management Ltd Llc holds 701,583 shs. 4,904 are held by Trexquant Inv Ltd Partnership. Systematic Lp has 12,739 shs. Meeder Asset Management holds 0.01% or 735 shs in its capital. Utah Retirement Systems stated it has 0.02% in Charles River Laboratories International, Inc. (NYSE:CRL). Royal Savings Bank Of Canada holds 390,330 shs or 0.02% of its capital. Yorktown Mgmt & Research owns 3,000 shs or 0.09% of their US capital. Cambridge owns 2,000 shs for 0.08% of their capital. Sei Invs Com, Pennsylvania-based fund reported 164,749 shs. Raymond James Advsrs has 0% invested in Charles River Laboratories International, Inc. (NYSE:CRL).

Charles River Laboratories International, Inc. had 24 selling transactions and 0 buys since January 2, 2018. This’s net activity of $11.12 million. Shares for $2.64 million were sold by FOSTER JAMES C on Tuesday, March 6. On Tuesday, March 6 the insider Girshick Birgit sold $1.08 million. 300 shs valued at $34,665 were sold by MASSARO GEORGE on Monday, June 25. On Wednesday, February 21 Shares for $250,741 were sold by Barbo William D. Shares for $890,100 were sold by MILNE GEORGE M JR. On Thursday, February 15 Shares for $312,172 were sold by CHUBB STEPHEN D.

Charles River Laboratories International, Inc. (NYSE:CRL) Ratings Coverage

Total analysts of 10 have positions in Charles River (NYSE:CRL) as follows: 5 rated it a “Buy”, 0 with “Sell” and 5 with “Hold”. The positive are 50%. Since January 19, 2018 according to StockzIntelligence Inc Charles River has 11 analyst reports. On Wednesday, March 14 the stock of Charles River Laboratories International, Inc. (NYSE:CRL) earned “Equal-Weight” rating by Morgan Stanley. The company rating was maintained by Jefferies on Tuesday, April 24. On Friday, June 15 the stock of Charles River Laboratories International, Inc. (NYSE:CRL) earned “Overweight” rating by KeyBanc Capital Markets. On Tuesday, February 13 the firm has “Buy” rating given by Robert W. Baird. The company rating was downgraded by SunTrust on Monday, January 22. On Wednesday, February 14 the stock of Charles River Laboratories International, Inc. (NYSE:CRL) has “Buy” rating given by SunTrust. On Wednesday, February 14 the rating was maintained by JP Morgan with “Overweight”. On Friday, April 20 the firm has “Hold” rating by MUFG Securities Americas Inc given. In Tuesday, February 13 report RBC Capital Markets maintained it with “Hold” rating and $116.0 target.

For more Charles River Laboratories International, Inc. (NYSE:CRL) news brought out recently go to: Benzinga.com, 247Wallst.com, Businesswire.com, Benzinga.com or Seekingalpha.com. The titles are as follows: “The Market In 5 Minutes: Tariffs, NXPI, Powell And More” brought out on June 15, 2018, “Top Analyst Upgrades and Downgrades: Advanced Micro Devices, Delphi, Domino’s Pizza, Southwest Airlines, Square …” on June 15, 2018, “Charles River Laboratories to Present at Jefferies and William Blair Conferences” with a publish date: June 04, 2018, “Benzinga’s Top Upgrades, Downgrades For June 15, 2018” and the last “Venture Capital Deals Of The Week: Ant Financial Gets $14B Ahead Of IPO” with publication date: June 09, 2018.

Charles River Laboratories International, Inc. (NYSE:CRL) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: